Drug recall · July 18, 2018
Buffered Lidocaine 1% with Sodium Bicarbonate Injection for Local Anesthetic Use recall
Why: Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Buffered Lidocaine 1% with Sodium Bicarbonate Injection for Local Anesthetic Use (Concentration=10 mg/mL) 0.25 mL Total Volume, Rx only , SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205 877-550-5059
- Lots / codes
Lot #: 20180507@21, Exp 7/1/2018; 20180511@9, 20180511@24, Exp 7/5/2018; 20180518@24, 20180518@31, 20180518@32, Exp 7/12/2018; 20180531@21, Exp 7/25/2018; 20180601@11, Exp 7/26/2018
- Quantity
- 3984 syringes
- Company
- SCA Pharmaceuticals, Little Rock, AR
- Distribution
- United States
- Initiated
- June 29, 2018 · Voluntary: Firm initiated
- Classified
- July 12, 2018
- Reported
- July 18, 2018
- Ended
- May 1, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.